Real-time enrollment status for this cystic fibrosis clinical trial
Current Status
Recruiting
Checked: March 2, 2026 at 10:33 AM UTC
| NCT Number | NCT05422222 |
| Recruiting Status | Recruiting |
| Condition | Cystic Fibrosis |
| Phase | Clinical Trial |
| Target Enrollment | 210 participants |
| Active Locations | 19 sites in the US |
| Sponsor | Vertex Pharmaceuticals Incorporated |
| Last Updated on CT.gov | November 6, 2025 (Nov 6, 2025) |
As of March 2, 2026: Clinical trial NCT05422222 is currently recruiting participants. This clinical trial study for cystic fibrosis is actively seeking new participants at 19 locations across the United States. The study is sponsored by Vertex Pharmaceuticals Incorporated. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05422222 is actively recruiting participants as of March 2, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 19 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05422222 was last updated Nov 6, 2025 (November 6, 2025). HelloStudys verifies this status automatically.